argenex SE (ARGX) vs Roivant Sciences Ltd. (ROIV)
- argenex SE ARGX 819.14 −3.21%
- Roivant Sciences Ltd. ROIV 33.53 −1.50%
argenex SE and Roivant Sciences Ltd. are both Biotechnology companies. argenex SE is the larger, with a market value of $53.2B against $24.6B — 2.2× the size. Roivant Sciences Ltd. has negative trailing earnings, so its P/E is not meaningful; argenex SE trades at 29.6×. argenex SE grew revenue faster over the last twelve months: 70.6% against −67.6%. argenex SE has the higher net margin (32.2% vs −3,535.0%) and the higher return on invested capital (20.7% vs −34.5%). Across the 17 metrics below, argenex SE leads on 15 and Roivant Sciences Ltd. on 2.
Valuation
Profitability
| Metric | ARGX | ROIV | Biotechnology median |
|---|---|---|---|
| Gross margin | 90.15% | 81.21% | 65.16% |
| Operating margin | 30.06% | (7,914.75%) | 0.00% |
| Net margin | 32.20% | (3,534.96%) | 0.00% |
| Free cash flow margin | 25.87% | (10,901.00%) | 0.00% |
| Return on equity | 27.07% | (5.47%) | (56.36%) |
| Return on assets | 23.15% | (5.15%) | (48.04%) |
| Return on invested capital | 20.71% | (34.51%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack